Operating Income for Cencora (COR)
According to Cencora's latest reported financial statements, the company's current operating income (TTM) is $3.87B USD. Operating income is profit from core operations: revenue minus cost of goods sold and operating expenses (SG&A, R&D). It excludes interest, taxes, and non-operating items, so it isolates how profitable the business itself is before financing and tax decisions. Compare with EBITDA and net income.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
COR
Currently viewingOperating IncomeSwitch metric
TTM (last 4 quarters)
$3.87B
YoY change
+20.0%
5Y CAGR
+12.5%
Peak year (2025)
$3.65B
Cumulative operating income
$38.40B
Operating Income history chart for Cencora (COR) from 1994 to 2025
Operating Income history table for Cencora (COR) from 1994 to 2025
| Fiscal year | Period ended | Reported | Operating Income | YoY |
|---|---|---|---|---|
| 2025 | $3.65B | +20.0% | ||
| 2024 | $3.04B | +24.3% | ||
| 2023 | $2.45B | -11.1% | ||
| 2022 | $2.75B | +2.9% | ||
| 2021 | $2.68B | +32.1% | ||
| 2020 | $2.02B | +8.5% | ||
| 2019 | $1.87B | +13.1% | ||
| 2018 | $1.65B | -18.2% | ||
| 2017 | $2.02B | +19.9% | ||
| 2016 | $1.68B | +28.7% | ||
| 2015 | $1.31B | +10.3% | ||
| 2014 | $1.19B | +19.9% | ||
| 2013 | $989.02M | -23.0% | ||
| 2012 | $1.28B | +4.3% | ||
| 2011 | $1.23B | +13.1% | ||
| 2010 | $1.09B | +21.0% | ||
| 2009 | $899.13M | +9.2% | ||
| 2008 | $823.54M | +4.7% | ||
| 2007 | $786.61M | +8.1% | ||
| 2006 | $727.93M | +16.5% | ||
| 2005 | $624.83M | -28.2% | ||
| 2004 | $870.48M | -1.4% | ||
| 2003 | $883.11M | +22.9% | ||
| 2002 | $718.43M | +177.0% | ||
| 2001 | $259.38M | +29.4% | ||
| 2000 | $200.43M | +15.3% | ||
| 1999 | $173.90M | +14.7% | ||
| 1998 | $151.60M | +26.8% | ||
| 1997 | $119.60M | +22.2% | ||
| 1996 | $97.90M | +0.1% | ||
| 1995 | $97.80M | +25.5% | ||
| 1994 | $77.90M | — |
Operating Income values are taken from Cencora's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
Cencora (COR) most recent annual operating income stands at $3.65B (2025) – grew 20.0% year-over-year.
Across 2020–2025 (5 years), Cencora operating income produced a CAGR of +12.5% – sustaining 2 straight years of year-over-year growth.
The dataset's maximum operating income sits at $3.65B (2025); the minimum reading of $77.90M dates to 1994.
Cencora (COR) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $22.84B.
Cencora Operating Income by Year
Cencora Operating Income 2025: $3.65B
Cencora operating income in 2025 was $3.65B, grew 20.0% from 2024. This figure represents the highest annual value in the available history.
Cencora Operating Income 2024: $3.04B
Cencora operating income in 2024 was $3.04B, grew 24.3% from 2023.
Cencora Operating Income 2023: $2.45B
Cencora operating income in 2023 was $2.45B, declined 11.1% below 2022.
Cencora Operating Income 2022: $2.75B
Cencora operating income in 2022 was $2.75B, edged up 2.9% from 2021.
Cencora Operating Income 2021: $2.68B
Cencora operating income in 2021 was $2.68B.
See more financial history for Cencora (COR).
Sector peers — Operating Income
Companies in the same sector as Cencora, ranked by their latest operating income.
| Company | Operating Income | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $127.66B | Healthcare |
| Eli Lilly and Company (LLY) | $29.70B | Healthcare |
| Merck & Co., Inc. (MRK) | $26.78B | Healthcare |
| Johnson & Johnson (JNJ) | $25.60B | Healthcare |
| AbbVie Inc. (ABBV) | $20.09B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $18.96B | Healthcare |
| AstraZeneca PLC (AZN) | $13.74B | Healthcare |
| Amgen Inc. (AMGN) | $10.68B | Healthcare |
Frequently asked questions
What is Cencora's operating income?
- Latest reported operating income for Cencora (COR) is $3.87B (period ending December 31, 2025).
How has Cencora operating income changed year-over-year?
- Cencora (COR) operating income changed +20.0% year-over-year on the latest annual filing.
What is the long-term growth rate of Cencora operating income?
- Cencora (COR) operating income compound annual growth rate is +12.5% over the most recent 5 years available.
When did Cencora operating income hit its highest annual value?
- Cencora operating income reached its highest annual value of $3.65B in 2025.
What was Cencora operating income in 2024?
- Cencora (COR) operating income in 2024 was $3.04B.
What was Cencora operating income in 2025?
- Cencora (COR) operating income in 2025 was $3.65B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
COR Overview
Company profile, financial tools, and key metrics
COR Revenue Counter
Earns $10,330 every second. See per minute, hour, and day.
COR Earnings Counter
Earns $51.54 per second net profit. See per minute, hour, and day.
COR Economic Scale
Exceeds Portugal's GDP. Compare with world economies.
COR What If Invested
What if you had invested $1,000? See historical returns from any date.
COR How It Makes Money
Discover visual breakdown of $325.78B in revenue — where it comes from and where it goes.
COR Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
COR Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
COR Daily Price Character
Steady · 51.0% historical win rate (green days). Streaks & record days.
COR Buybacks
0.08% TTM buyback yield. Shareholder yield & SBC comparison.
COR Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
COR Dividend Profile
Yield: 0.74%. Safety: 6/8. See full history.
COR Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
COR Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.